Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Leveraging AI to Improve Patient Outcomes in Healthcare

The importance of providing patients with a fast and accurate diagnosis cannot be overstated – it can be the difference between life and death. Unfortunately, the healthcare system is overwhelmed, and physicians cannot keep up with the overflow of patient needs in a timely manner. Dr. Chai Xiangfei, CEO and co-founder at HY Medical, and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The importance of providing patients with a fast and accurate diagnosis cannot be overstated – it can be the difference between life and death. Unfortunately, the healthcare system is overwhelmed, and physicians cannot keep up with the overflow of patient needs in a timely manner.

Dr. Chai Xiangfei, CEO and co-founder at HY Medical, and Beenish Zia, chief architect of medical imaging at Intel, sit down with podcast host, Tyler Kern, to discuss the current challenges of providing a patient diagnosis in a timely manner and how artificial intelligence (AI) solutions can help.

Beenish discusses and highlights the complexities of diagnosing patient illnesses. “Medical diagnosis is a complex process which requires clinical skills and the need for clear decisions. And it needs to be balanced with acceptance for the ambiguity of many clinical situations,” Beenish explains.

According to Beenish, there are five major obstacles that delay diagnosis:

  1. There are variations in individual logic and processes.
  2. Because the nature of the evidence is not clear, further tests/screenings are required.
  3. Standards vary globally, which causes longer diagnosis times.
  4. Lack of evidence and data from diverse populations leads to not having good data sets to represent different communities.
  5. The number of cases a physician must handle grows daily.

“For example, in certain hospitals in New York, we have heard that the radiologists get more than 1400 scans per day, and maybe there is just like a handful of radiologists to look at them. So, just the huge imbalance between the number of cases requiring diagnosis and the medical staff available to provide the diagnosis is not good,” Beenish explains.

To address this need, Dr. Chai talks about the role of AI in reducing diagnosis time to improve patient outcomes. “There are a huge amount of images created every day. In the meantime, actually, there’s a shortage of radiologists to read images. So, the real situation is that because there is a long waiting list of imaging… it can take hours or even days” for patients to get the result of their tests, notes Dr. Chai.

With traditional processes, scans are taken and added to a waiting list to be read and interpreted by radiologists, which can take up to 15 minutes. Current AI technology can give initial results within one minute and can ultimately reduce reading time by 30%. When radiology staff and doctors get the initial results, they can then quickly review the areas highlighted by the AI and then determine a path forward for diagnosis and treatments. Having this reduction in reading time, is helping patients get treated sooner.

To learn more about how AI can transform the diagnostic process and improve patient outcomes, connect with Dr. Chai Xiangfei and Beenish Zia on LinkedIn.

To find out more about HY Medical please visit: https://www.huiyihuiying.com/#page1.

Learn about various technologies Intel offers to advance the healthcare field — from compute to storage and networking to AI — visit: https://www.intel.com/content/www/us/en/healthcare-it/healthcare-overview.html

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512